Target intelligence / Profile preview

Lipid metabolism regulation gene

Molecular classification
Other (gene family; not a single molecular entity), Enzyme (for specific members such as fatty acid synthase), Transporter (for specific members such as ABCA1, ABCA7), Receptor (for some genes encoding receptors involved in lipid signaling), Transcription factor (e.g., SREBP)
01

Overview

"Lipid metabolism regulation genes" refers to a broad set of genes involved in controlling the synthesis, breakdown, transport, and storage of lipids within cells and tissues. This category includes enzymes responsible for biosynthetic steps (such as fatty acid synthase), transporters mediating movement across membranes (such as ABCA1), nuclear receptors/transcription factors regulating expression patterns in response to cellular signals or nutrient status (such as PPARα and SREBP), and proteins involved in lipoprotein assembly/remodeling. These genes are implicated in numerous physiological processes including energy balance and membrane composition. Alterations or dysregulation among these genes contribute to major diseases such as cardiovascular disorders—where they influence cholesterol/lipoprotein profiles—neurodegenerative diseases like Alzheimer’s through effects on brain lipid homeostasis, cancer via changes supporting tumor growth/metabolism, obesity/metabolic syndrome, among others. While many individual "lipid metabolism regulation" proteins are considered therapeutic targets—with several drugs already approved targeting them—the term itself does not refer to one discrete molecular entity but rather an entire functional class spanning multiple protein families. Therefore it is not appropriate to treat "lipid metabolism regulation gene" itself as a canonical drug target; instead each member should be considered individually for structured data purposes. “Current therapeutic targets for lipid-related cardiovascular risk primarily include Lp(a), HDL-C, LDL-C, ABCA1, ANGPTL3, APOC3,CETP , PCSK9 ,and PPARα…most drug developments targeting these molecules are still in clinical or preclinical stages.” [1] “APOE,TREM2 ,APOJ,PICALM,SREBP‐2 ,ABCA1,and ABCA7 are involved in lipid trafficking and metabolism…This study identified differentially expressed lipid-metabolism–related genes…emphasizing their role …and potential therapeutic targets.” [2]

Other names
Lipid metabolism-related genelipid regulatory genelipid metabolism-associated gene
02

Mechanism of action

Varies by individual target within the group. Examples include: - Inhibition of cholesterol synthesis enzymes - Modulation of lipoprotein processing or clearance from plasma - Activation or inhibition of nuclear receptors regulating transcription of metabolic genes

03

Biological functions

Regulation of lipid biosynthesisRegulation of lipid transport and traffickingCellular energy homeostasisSignal transduction related to metabolic pathwaysModulation of inflammation and immune response
04

Disease associations

Cardiovascular diseaseNeurodegenerative disease (notably Alzheimer’s disease)CancerMetabolic syndrome/obesity/diabetes
05

Safety considerations

Safety concerns depend on the specific target and drug. General issues may include liver toxicity, muscle toxicity with statins/fibrates, off-target effects on other metabolic pathways. For some targets like PCSK9 or CETP inhibition, long-term safety is still under investigation.
06

Interacting drugs

Statins (targeting HMG-CoA reductase)

5 more in the full profile.

07

Biomarkers

Individual genes/proteins may serve as biomarkers for patient selection or efficacy monitoring; examples include LDL-C levels, HDL-C levels, Lp(a), APOE genotype for Alzheimer’s risk stratification.

Beyond the preview

Go deeper on Lipid metabolism regulation gene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid metabolism regulation gene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call